Location History:
- Solon, OH (US) (2011)
- Charlottesville, VA (US) (2017)
Company Filing History:
Years Active: 2011-2017
Title: Innovations in Prostate Disease Treatments by Danny R. Gray
Introduction
Danny R. Gray, an accomplished inventor based in Charlottesville, VA, has made significant contributions to the medical field with a focus on prostate disease treatments. As an inventor with two patents to his name, Gray is dedicated to advancing our understanding and management of prostatic diseases, including benign prostatic hyperplasia and various forms of prostate cancer.
Latest Patents
Gray's latest patents detail innovative methods for evaluating and implementing treatments for prostate diseases. His first patented method involves the evaluation of test agents as potential candidates for treating prostatic diseases. The process includes using a mouse model with a human prostate primary xenograft, which contains human endothelial cells. By initiating androgen deprivation in the mouse and administering test agents within a critical time window, the method assesses reductions in human epithelial cells and blood vessels within the xenograft.
Moreover, his patented method also outlines a therapeutic approach for individuals suffering from human prostate cancer or benign prostatic hyperplasia. This approach comprises initiating androgen deprivation in patients and administering agents that induce apoptosis in vascular endothelial cells shortly after therapy begins. These innovative methods signify a notable step forward in the treatment of prostate-related conditions.
Career Highlights
Gray is currently associated with Health Research, Inc., where he focuses on the development of novel methods for treating serious medical conditions. His deep understanding of prostate diseases and therapeutic methodologies has positioned him as a key player in this important field of study.
Collaborations
Throughout his career, Gray has collaborated with notable colleagues, including Gary Smith and Howard M. Reisner, contributing to a collective effort aimed at advancing the science behind prostate disease treatments. These professional partnerships have enriched his research experience and have been instrumental in the development of his innovative methodologies.
Conclusion
Danny R. Gray's commitment to research and innovation in the field of prostate disease treatments continues to pave the way for new therapeutic options. With his two impactful patents, he exemplifies the role of inventors in advancing medical science and enhancing patient care. His work represents a vital contribution to the ongoing battle against prostate-related health challenges.